The absolute eosinophil count (AEC) on a routine complete blood count could be a useful addition when deciding which patients to work up for RA-ILD.
Recent News
Read ArticleIn this week's RheumNow podcast, Dr. Cush makes a case for using your best drug first in rheumatoid arthritis.
Investigators presented an abstract using Epic Cosmos to examine pregnancy outcomes in women with SLE across health systems nationwide. Beyond confirming that SLE pregnancies remain higher risk, the study highlights two important opportunities: the ability to use large-scale, real-world data to study relatively uncommon outcomes in lupus, and the importance of lupus nephritis history when counseling patients and planning pregnancy.
We are missing some key data which we were promised, and we want and deserve to know how this story ends.
We have spent years telling patients with PsA that weight loss may improve symptoms and reduce cardiometabolic risk. A new ACR 2026 abstract asks the more provocative question: could GLP-1–based therapy influence PsA outcomes even after accounting for the change on the scale?
When axSpA does not respond to treatment and both the clinician and patient perceive this is a problem, we call it difficult to manage. Is the disease difficult, or are we failing to see it clearly?
It is encouraging to see a new treatment option for fibromyalgia after more than 15 years without a new FDA-approved therapy. But we should look beyond whether a trial met its statistical endpoint and ask a more practical question: how much better did patients actually feel?

Poster Hall